ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Research Alliance Corp. I Announces Effectiveness of Registration Statement for Proposed Business Combination with POINT
June 10, 2021Therapeutics Acquisition Corp, d/b/a Research Alliance Corp. I, a Delaware corporation ("the Company") (Nasdaq: RACA) announced today that its registration statement on Form S-4 (File Number 333-254600) (as amended, the "Registration Statement" -
Novartis buys Endocyte for $2.1 billion
October 19, 2018Novartis has signed a deal to acquire US biopharma Endocyte, securing itself access to novel radiopharmaceutical programmes “with significant sales potential”.
Pharma Sources Insight January 2025
